Joining the session is Dr. Collin Hovinga, Senior Vice President of Rare and Orphan Disease Programs at C-Path, underscoring the importance of regulatory science tools and qualification of Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results